Yantai Zhenghai Biotechnology Co., Ltd.

Total Valuation

Yantai Zhenghai Biotechnology Co., Ltd. carries a market capitalization of 2.67B, placing it among publicly traded companies globally. Its enterprise value stands at 3.05B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Yantai Zhenghai Biotechnology Co., Ltd. currently has 180.00M shares outstanding.

Valuation Ratios

Yantai Zhenghai Biotechnology Co., Ltd. trades at a trailing price-to-earnings ratio of 38.27. The price-to-sales ratio is 10.31, and the price-to-book ratio stands at 5.73.

Enterprise Valuation

On an enterprise value basis, Yantai Zhenghai Biotechnology Co., Ltd. trades at an EV/EBITDA multiple of 34.02 and an EV/FCF ratio of 219.31. The EV/Sales ratio of 8.65 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 34.02 provides insight into valuation relative to core operating earnings.

Financial Position

Yantai Zhenghai Biotechnology Co., Ltd. maintains a current ratio of 8.92, meaning it holds 8.9x the short-term assets needed to cover near-term liabilities.

Financial Efficiency

Yantai Zhenghai Biotechnology Co., Ltd. posts a return on equity of 15.14 and a return on invested capital of 9.32.

Taxes

Over the trailing twelve months, Yantai Zhenghai Biotechnology Co., Ltd. has paid 10.13M in income taxes, reflecting an effective tax rate of 9.63.

Stock Price Statistics

Yantai Zhenghai Biotechnology Co., Ltd.'s stock has declined approximately -27.03883% over the past 52 weeks. The 50-day moving average sits at 16.34, while the 200-day moving average is 19.40.

Income Statement

Over the trailing twelve months, Yantai Zhenghai Biotechnology Co., Ltd. generated 353.04M in revenue and converted that into 95.09M in net income, yielding earnings per share of 0.54. EBITDA reached 89.73M, while operating income came in at 89.73M.

Balance Sheet

Total book value stands at 634.86M, with working capital of 607.00M providing operational flexibility.

Cash Flow

After subtracting -13.91M in capital expenditures, free cash flow totaled -13.91M - equivalent to -0.08 per share.

Margins

Yantai Zhenghai Biotechnology Co., Ltd. operates with a gross margin of 86.17, reflecting its pricing power and cost economics. The operating margin of 25.42 and net profit margin of 26.94 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Yantai Zhenghai Biotechnology Co., Ltd.'s most recent stock split took place on May 19, 2022 with a 2:3 split ratio.

Scores

Yantai Zhenghai Biotechnology Co., Ltd. posts an Altman Z-Score of 27.29, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.